The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapy
- 25 July 2014
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 29, 21-31
- https://doi.org/10.1016/j.semcancer.2014.07.005
Abstract
No abstract availableKeywords
Funding Information
- CLL Global Research Foundation
- The Torsten and Regnar Söderberg Foundation (MT9/12, MT4/13)
- Cancer and Allergy Foundation (149351, 149746, 150288)
- Swedish Research Council (K2013-64X-21464-04-3)
- Swedish Cancer Society (CAN 2009/852)
- Cancer Society in Stockholm (121332)
- King Gustaf Vth Jubilee Fund (124272)
- Felix Mindus Foundation (2013mind39290)
- VINNOVA (348-2005-6481)
- Karolinska Institute Foundations
- AFA Insurance (130054)
- Stockholm County Council (20120051)
This publication has 95 references indexed in Scilit:
- Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma CellsPLOS ONE, 2013
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human CancersThe American Journal of Pathology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A Tissue-Specific Atlas of Mouse Protein Phosphorylation and ExpressionCell, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Ror1-Ror2 complexes modulate synapse formation in hippocampal neuronsNeuroscience, 2010
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domainsProceedings of the National Academy of Sciences of the United States of America, 2009
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5aProceedings of the National Academy of Sciences of the United States of America, 2008
- Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migrationThe Journal of cell biology, 2006
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004